The most notable companies in this group are Exact Sciences Corp (NASDAQ:EXAS).
The investment seeks to provide long-term capital appreciation.
Under normal market conditions, the fund invests at least 80% of its net assets (plus borrowings for investment purposes) in equity and equity-related securities of companies in the healthcare and life sciences sectors, including common stock, options, preferred stock and convertible debt. It may invest without limitation in securities of companies domiciled outside the United States either directly or through American Depositary Receipts ("ADRs"). The fund may invest in securities of companies of any market capitalization.
The average market capitalization across the Eventide Healthcare & Life Sciences I MF is 4.24B. The market cap for tickers in the group ranges from 579.62M to 29.35B. ARGX holds the highest valuation in this group at 29.35B. The lowest valued company is COGT at 579.62M.
The average weekly volume growth across all stocks in the Eventide Healthcare & Life Sciences I MF was 181%. For the same stocks of the MF, the average monthly volume growth was -24% and the average quarterly volume growth was 2%
Fundamental Analysis Ratings
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Valuation Rating: 55
P/E Growth Rating: 97
Price Growth Rating: 54
SMR Rating: 89
Profit Risk Rating: 89
Seasonality Score: 19 (-100 ... +100)